Ironwood Pharmaceuticals, Inc. (IRWD) P/B ratio

P/B ratio · fiscal 2022
3.5×

The P/B ratio of Ironwood Pharmaceuticals, Inc. (IRWD) was 3.5× at the end of fiscal 2022 (December 31, 2022). That is 11.8% higher than the 3.2× of fiscal 2021. Figures as of 18 Nov 2026, 10:46 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/B ratio, fiscal 2022
3.5×
Change on fiscal 2021
+11.8%
Highest on record
29.2×fiscal 2020
Lowest on record
3.2×fiscal 2021
Fiscal years on record
52010–2022

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Ironwood Pharmaceuticals, Inc. P/B ratio, in more detail

Across the 5 fiscal year-ends on record (2010–2022), the highest was 29.2× in fiscal 2020 and the lowest 3.2× in fiscal 2021.

History · 5 fiscal years

P/B ratio at each fiscal year-end

Ironwood Pharmaceuticals, Inc. P/B ratio, year by year

Ironwood Pharmaceuticals, Inc. (IRWD) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
2025——$3.37-$1.61
2024——$4.43-$1.88
2023——$11.44-$2.23
20223.5× 11.8% up$12.39$3.50
20213.2× 89.2% down$11.66$3.69
202029.2×—$11.39$0.39
2019——$13.31-$0.60
2018——$8.68-$1.29
2017——$12.55—
2016——$12.81—
2015——$9.71—
2014——$12.83—
2013——$9.72—
2012——$9.28—
201110.9× 87.1% up$10.03$0.92
20105.8×—$8.67$1.49
2009———-$35.11

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

More on IRWD

Ironwood Pharmaceuticals, Inc., figure by figure

Ironwood Pharmaceuticals, Inc. (IRWD) overview: price, valuation and scorecard

Ironwood Pharmaceuticals, Inc. P/B ratio: questions and answers

What is Ironwood Pharmaceuticals, Inc.'s P/B ratio?

The P/B ratio of Ironwood Pharmaceuticals, Inc. (IRWD) was 3.5× at the end of fiscal 2022 (December 31, 2022). That is 11.8% higher than the 3.2× of fiscal 2021.

What are the highest and lowest P/B ratio figures on record for Ironwood Pharmaceuticals, Inc.?

Across the 5 fiscal year-ends on record (2010–2022), the highest was 29.2× in fiscal 2020 and the lowest 3.2× in fiscal 2021.

How is Ironwood Pharmaceuticals, Inc.'s P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B. For Ironwood Pharmaceuticals, Inc. it is on record here for 5 fiscal years, 2010 to 2022.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ironwood Pharmaceuticals, Inc. (IRWD) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/IRWD/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.